ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #5,225Hybrid

Multiple Sclerosis and Related Disorders

Acronym:msard
•
Abbreviation (ISO):MULT SCLER RELAT DIS
•
Identifier (ISSN):2211-0348(Print)/2211-0356(Online)
•
Publisher:Elsevier
Clarivate IF (2026)
3↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Multiple Sclerosis and Related Disorders

WoS Q2
13573.220182.7320192.8920204.3420214.812022420232.920242.9202532026
Annual Impact Factor Metric
Current (2026):3
Scopus SJR & RankScopus Q1
0.959
#5,225

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
77

77 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate13.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
510articles/year
22.66% Gold OA•87.7% Original Research

Aims & Scope

Multiple Sclerosis is an area of ever expanding research and escalating publications. Multiple Sclerosis and Related Disorders is a wide ranging international journal supported by key researchers from all neuroscience domains that focus on MS and associated disease of the central nervous system. The primary aim of this new journal is the rapid publication of high quality original research in the field. Important secondary aims will be timely updates and editorials on important scientific and clinical care advances, controversies in the field, and invited opinion articles from current thought leaders on topical issues. One section of the journal will focus on teaching, written to enhance the practice of community and academic neurologists involved in the care of MS patients. Summaries of key articles written for a lay audience will be provided as an on-line resource. A team of four chief editors is supported by leading section editors who will commission and appraise original and review articles concerning: clinical neurology, neuroimaging, neuropathology, neuroepidemiology, therapeutics, genetics / transcriptomics, experimental models, neuroimmunology, biomarkers, neuropsychology, neurorehabilitation, measurement scales, teaching, neuroethics and lay communication.

Topics Covered (Recognized by AI)
MedicineBiologyPsychologyPsychiatryImmunologyInternal MedicinePathologyGeneticsPathology & DiseasesNeuroscienceSurgeryMathematicsStatisticsAntibodies & ImmunologyChemistryPhysical TherapyEndocrinologyRadiology
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CLINICAL NEUROLOGY

Q2
Rank133/296
IndexSCIE
JCISCIE2026

CLINICAL NEUROLOGY

Q2
Rank115/296
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3
Articles / Year651
Total Citations114
2025
IF2.9
Articles / Year569
Total Citations1,112
2024
IF2.9
Articles / Year699
Total Citations2,964
2023
IF4
Articles / Year853
Total Citations4,854
2022
IF4.808
Articles / Year744
Total Citations8,282

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,225Scopus Q1SCImago Profile
Scopus Coverage:2012-2026
Scopus Broad Areas:MedicineNeuroscience
Scopus Citation Rank (SJR)Q1
0.959

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
2.82

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,320 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations5,089
3-Year Documents1,777
Citable Documents1,589

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate50.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1
NeurologyQ2
Neurology (clinical)Q2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 13.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区CLINICAL NEUROLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Multiple Sclerosis and Related Disorders (acronym: msard, abbr: MULT SCLER RELAT DIS, ISSN: 2211-0348) is a peer-reviewed international scholarly journal in the field of CLINICAL NEUROLOGY, published by Elsevier in England. The periodical holds a Journal Impact Factor (JIF) of 3.00, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.959 (Q1), an H-index of 77.

The journal enforces rigorous peer evaluation with an annual output of approximately 510 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,320 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEScopusPubMed
Editorial Address
THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 4c762eb2-9050-40bf-b6a7-ee09839e0ce6
Database Updated: 2026-10-16